Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ryan

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
AIDS Research and Human Retroviruses|February 23, 2012
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeksJudith A Aberg, Pablo Tebas, Edgar Turner Overton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 14, 2021
Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergyCaroline Nilsson, Amy M Scurlock, Evan S Dellon, et al.
The Journal of Surgical Research|March 21, 2015
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results databaseRobert Ryan Meyerhoff, Chi-Fu Jeffrey Yang, Paul J Speicher, et al.
Pain Medicine (Malden, Mass.)|May 31, 2020
Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)Gladstone C McDowell, Michael F Saulino, Mark Wallace, et al.
Frontiers in Ophthalmology|July 10, 2024
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trialNeda Gioia, Jeffry Gerson, Robert Ryan, et al.
Patient Preference and Adherence|February 19, 2026
Perspectives of Healthcare Professionals on the Treatment Landscape of Ocular RednessMelissa M Toyos, Katie Forster, Sara Savar, et al.
Journal of Environmental Radioactivity|October 5, 2023
Experiences from the ARGOS user group nuclear emergency exerciseBlake Orr, Agnieszka Hac-Heimburg, Naeem Ul Hasan Syed, et al.
Clinical and Translational Allergy|January 28, 2024
Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trialCaroline Nilsson, Andrea Vereda, Magnus P Borres, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2010
Efficacy, safety, and tolerability of etravirine with and without darunavir/ritonavir or raltegravir in treatment-experienced patients: analysis of the etravirine early access program in the United StatesWilliam Towner, Jacob Lalezari, Michael G Sension, et al.
Frontiers in Allergy|January 26, 2023
IgE epitopes of Ara h 9, Jug r 3, and Pru p 3 in peanut-allergic individuals from Spain and the USChristina M Kronfel, Hsiaopo Cheng, Jane K McBride, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
AIDS Research and Human Retroviruses|February 23, 2012
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeksJudith A Aberg, Pablo Tebas, Edgar Turner Overton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 14, 2021
Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergyCaroline Nilsson, Amy M Scurlock, Evan S Dellon, et al.
The Journal of Surgical Research|March 21, 2015
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results databaseRobert Ryan Meyerhoff, Chi-Fu Jeffrey Yang, Paul J Speicher, et al.
Pain Medicine (Malden, Mass.)|May 31, 2020
Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)Gladstone C McDowell, Michael F Saulino, Mark Wallace, et al.
Frontiers in Ophthalmology|July 10, 2024
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trialNeda Gioia, Jeffry Gerson, Robert Ryan, et al.
Patient Preference and Adherence|February 19, 2026
Perspectives of Healthcare Professionals on the Treatment Landscape of Ocular RednessMelissa M Toyos, Katie Forster, Sara Savar, et al.
Journal of Environmental Radioactivity|October 5, 2023
Experiences from the ARGOS user group nuclear emergency exerciseBlake Orr, Agnieszka Hac-Heimburg, Naeem Ul Hasan Syed, et al.
Clinical and Translational Allergy|January 28, 2024
Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trialCaroline Nilsson, Andrea Vereda, Magnus P Borres, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2010
Efficacy, safety, and tolerability of etravirine with and without darunavir/ritonavir or raltegravir in treatment-experienced patients: analysis of the etravirine early access program in the United StatesWilliam Towner, Jacob Lalezari, Michael G Sension, et al.
Frontiers in Allergy|January 26, 2023
IgE epitopes of Ara h 9, Jug r 3, and Pru p 3 in peanut-allergic individuals from Spain and the USChristina M Kronfel, Hsiaopo Cheng, Jane K McBride, et al.
Pageof 8